NEC Baby Formula (Similac/Enfamil) Lawsuit in Oklahoma

Necrotizing Enterocolitis (NEC) is a life-threatening inflammatory disease of the intestines that primarily strikes premature and low-birthweight infants in the Neonatal Intensive Care Unit. In NEC, bacteria invade the immature intestinal wall, causing progressive tissue death (necrosis), which can lead to bowel perforation, bacterial sepsis, and multi-organ failure. NEC kills approximately 15,000 premature infants in the United States each year and is the leading cause of death from gastrointestinal disease in the NICU. Survivors often face lifelong consequences including Short Bowel Syndrome, TPN dependency, and neurodevelopmental disabilities.

NEC is caused by a combination of intestinal immaturity, dysbiosis (abnormal gut bacteria), and inflammatory triggers. The immature premature gut lacks the protective defenses that develop in the final trimester of pregnancy. Cow's milk-based formula — unlike human breast milk — contains no IgA antibodies, lactoferrin, or bioactive oligosaccharides that protect the neonatal gut, and it promotes inflammatory bacterial growth. Decades of peer-reviewed research, including a landmark 1990 Lancet study and multiple Cochrane Reviews, have established that premature infants fed cow's milk-based formula are 2.4 to 10 times more likely to develop NEC than infants fed human breast milk.

The formulas at the center of the NEC litigation are cow's milk-based premature infant formulas marketed specifically for NICU use. These include Similac Special Care (manufactured by Abbott Laboratories) and Enfamil Premature (manufactured by Mead Johnson, now a subsidiary of Reckitt). Other Similac and Enfamil premature/NICU-specific products have also been implicated. Standard term infant formulas (Similac Advance, Enfamil NeuroPro) are not at issue — the litigation focuses specifically on premature formulas designed and marketed for use in the most vulnerable infants.

Your family may qualify if: (1) your infant was born premature (typically before 37 weeks, with the strongest cases involving infants born before 32 weeks); (2) your infant was fed Similac Special Care, Enfamil Premature, or another cow's milk-based premature formula in the NICU; (3) your infant was diagnosed with NEC confirmed by imaging, surgery, or pathology; and (4) your infant was harmed — including by surgery, bowel resection, short bowel syndrome, neurodevelopmental disability, or death. Contact an attorney even if the NEC occurred years ago — the statute of limitations is tolled for minor children in most states until age 18.

Yes. The majority of NEC formula lawsuits are filed on behalf of children who survived NEC but suffer permanent harm, including Short Bowel Syndrome, TPN dependency, and neurodevelopmental disabilities such as cerebral palsy and cognitive impairment. In fact, surviving children with serious permanent injuries often have the highest-value claims because their lifetime medical costs and care needs can be calculated and presented to a jury. Under the minor tolling rule, surviving children's personal injury claims are protected until age 18 in most states — giving families time to pursue claims even years after the NEC diagnosis.

The three critical categories of evidence are: (1) NICU medical records and feeding logs documenting which formula products were administered, in what amounts, and when; (2) medical records confirming the NEC diagnosis — radiology reports showing pneumatosis intestinalis or free air, operative reports, and pathology reports; and (3) records of the long-term consequences — surgical follow-up, short bowel syndrome management, nutritional support, developmental evaluations, and therapy records. Your attorney will assist in obtaining these records from the hospital and will work with expert neonatologists and pediatric surgeons to establish the causal connection between the formula and your baby's NEC.

MDL stands for Multi-District Litigation — a federal procedural mechanism that consolidates thousands of similar cases in one court for coordinated pretrial proceedings. NEC formula cases are consolidated in MDL No. 3026, In Re: Abbott Laboratories, et al., Preterm Infant Formula Products Liability Litigation, in the United States District Court for the Northern District of Illinois, before Chief Judge Rebecca R. Pallmeyer. The MDL coordinates discovery, expert witnesses, and bellwether trials. Bellwether trials allow representative cases to be tried before juries to gauge how the evidence plays out, which informs settlement negotiations for all cases in the MDL. Your individual case will be filed as a separate action and assigned a docket number within the MDL.

NEC formula cases are among the highest-value mass tort claims in the country. Settlement values range broadly based on the severity of the injury. Cases involving serious NEC with full recovery may settle in the $500,000-$1.2 million range. Cases with permanent bowel damage range from $1.2M-$2.5M. Cases with serious permanent disabilities such as Short Bowel Syndrome or cerebral palsy range from $2.5M-$4M. Wrongful death and catastrophic injury cases have produced settlements and jury verdicts ranging from $3.5M to over $65M in individual bellwether trials. MDL bellwether verdicts are actively shaping settlement discussions in 2026.

NICU records — particularly nursing flowsheets (feeding logs) — are essential to proving which formula products were administered to your baby. However, you do not need to have these records in hand before contacting an attorney. Your attorney will request and obtain the records for you through a medical records authorization. Hospitals are required to retain NICU records for extended periods (often 10 years for pediatric patients, sometimes longer). Even if you are not sure which formula your baby received, an attorney can investigate the hospital's purchasing records and NICU protocols to determine which products were used.

Yes, but the deadlines are more complex — and often more favorable — than in typical personal injury cases. For surviving children, the statute of limitations is tolled (paused) in most states until the child reaches age 18, giving the child until their late teens or early twenties to bring their own claim. For parents bringing claims on their own behalf (loss of consortium, wrongful death), the adult statute of limitations applies — typically 2-3 years from the date of the NEC diagnosis or death, sometimes extended by the discovery rule. Do not assume your claim is time-barred without consulting an attorney. Contact a NEC lawyer immediately to get an accurate assessment of your deadlines.

Potentially. In addition to suing Abbott and Mead Johnson as the formula manufacturers, families may have claims against the hospital or NICU if the medical team failed to follow evidence-based guidelines recommending human breast milk or donor breast milk for premature infants, failed to adequately inform parents of the NEC risk associated with cow's milk formula, or otherwise fell below the applicable standard of care. Hospital liability claims are typically evaluated as medical malpractice, which involves different legal standards and procedural requirements than product liability claims against the formula manufacturers. An experienced attorney can evaluate whether both types of claims apply to your situation.

In a NEC formula case, recoverable damages typically include: past and future medical expenses (emergency surgery, bowel resection, NICU stay, Short Bowel Syndrome management, TPN supplies, feeding tubes, developmental therapy, special education, and all future medical care); lost earning capacity (for children whose disabilities will affect their future employment); pain and suffering and loss of enjoyment of life; emotional distress; and in wrongful death cases, funeral and burial expenses, loss of consortium, and the family's loss of the child's society, companionship, and guidance. Punitive damages may be available if the evidence demonstrates that Abbott or Mead Johnson acted with conscious disregard for the safety of premature infants.